Demographic, Clinical, and Molecular Determinants of Quality of Life and Oxidative Stress in Multiple Sclerosis: A Cross-Sectional Study from Sulaymaniyah, Iraq.

This is the first study in Iraq to integrate socioeconomic, genetic, and oxidative stress markers in MS patients, revealing unique associations between HLA-DRB1 polymorphisms and relapsing-remitting MS (RRMS). This work investigated the demographic, clinical, oxidative stress, and molecular aspects influencing quality of life in multiple sclerosis patients in Sulaymaniyah, Iraq. A cross-sectional study was undertaken with 63 MS patients and 20 healthy controls to evaluate quality of life using the Multiple Sclerosis Quality of Life-54 (MSQoL-54) questionnaire. We compiled demographic and clinical information, including age, sex, educational level, socioeconomic level, multiple sclerosis phenotype, disease duration, and Expanded Disability Status Scale (EDSS) scores. In this work, single nucleotide polymorphism (SNP) of HLA-DRB1 was investigated in conjunction with oxidative stress markers, including MDA, 8-OHdG, and GPx activity, to the expression of the NRF2 gene. Significant relationships (p < 0.05) between quality of life and crucial variables, including the degree of the disease, level of education, socioeconomic level, and oxidative stress markers, were revealed by statistical analysis. MDA and 8-OHdG levels tightly predicted NRF2 expression (R = 0.713, p < 0.001 according to regression analysis). This result draws attention to an antioxidant response seeking to offset its lack of potency. All MS subtypes showed noticeably higher NRF2 expression than controls, according to post hoc analysis. PPMS showed the highest overexpression (p < 0.001). The results indicated the importance of oxidative stress markers in multiple sclerosis and how it affects quality of life. For this reason, personalized treatments must target both oxidative stress and socioeconomic status to help patients get better, especially in underdeveloped areas. Besides this, the study offers important information for legislators and medical practitioners creating thorough, patient-centered care plans to improve MS management. Furthermore, serum vitamin D3 levels varied greatly among MS subtypes (p = 0.008); PPMS patients had the lowest levels. Though p = 0.162, vitamin B12 levels did not approach statistical relevance; lower levels were observed in progressive MS forms, implying a possible function in disease pathogenesis. In this work, single nucleotide polymorphism (SNP) of HLA-DRB1 has been investigated together with oxidative stress markers including MDA, 8-OHdG, and GPx activity to NRF2 gene expression. Two RRMS patients showed the T risk allele (G > A transition at rs3135), indicating a possible genetic predisposition to MS in this cohort based on SNP analysis. Moreover, MS patients and healthy controls underwent genotyping analysis utilizing Sanger sequencing to evaluate the distribution of HLA-DRB1 rs3135388. More often detected in MS subtypes, especially in RRMS forms, the T allele supports a genetic susceptibility connected to oxidative stress dysregulation.